- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01017627
Impact of Adherence to Anemia Management Policy on Repeat Hospitalization in End Stage Renal Disease (ESRD)
April 1, 2010 updated by: Fresenius Medical Care North America
A Case Controlled Study to Determine the Impact of Adherence to Anemia Management Policy on Repeat Hospitalization in ESRD
The investigators hypothesize that the post-hospitalized patient status is characterized by subacute and reversible metabolic and hematological changes that, if addressed and treated in a timely manner, would result in a reduced risk for repeat hospitalization.
Consequently, a structured quality improvement program, focused on increasing adherence to company wide anemia management policies (ie hemoglobin monitoring within the first 3-5 days post-hospitalization, followed by an appropriate EPO dose modification within the 7 days post-hospitalization), will significantly decrease the risk of hospital re-admission in the 30 days after discharge.
Study Overview
Status
Unknown
Intervention / Treatment
Detailed Description
The post-hospitalization quality improvement project will be piloted across 30 Fresenius clinics. Targeted enrollment of 1500 episodes of hospitalization in which the patient returns after discharge to resume outpatient dialysis.
Patient outcomes will be followed for up to 30 days from the time of discharge from hospital.
Study Type
Interventional
Enrollment (Anticipated)
1500
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Denver, Colorado, United States, 80209
- Denver Central
-
-
Florida
-
Jacksonville, Florida, United States, 32246
- St. John's
-
Jacksonville, Florida, United States, 32250
- JAX Beach
-
-
Illinois
-
Chicago, Illinois, United States, 60616
- Prairie
-
-
Indiana
-
Decatur, Indiana, United States, 46733
- Tri Counties
-
Huntington, Indiana, United States, 46750
- Huntington
-
New Albany, Indiana, United States, 47150
- Floyd County
-
-
Kentucky
-
Louisville, Kentucky, United States, 40216
- South Louisville
-
-
Louisiana
-
Breaux Bridge, Louisiana, United States, 70517
- Breaux Bridge
-
Delta, Louisiana, United States, 71233
- Delta
-
Lafayette, Louisiana, United States, 70501
- East Lafayette
-
-
Massachusetts
-
Methuen, Massachusetts, United States, 01844
- Methuen
-
Roxbury, Massachusetts, United States, 02119
- Roxbury
-
-
Michigan
-
Battle Creek, Michigan, United States, 49014
- Battle Creek
-
East Lansing, Michigan, United States, 48823
- East Lansing
-
Kalamazoo, Michigan, United States, 49009
- Oshtemo
-
Lansing, Michigan, United States, 48911
- Lansing
-
Saginaw, Michigan, United States, 48602
- Saganaw Riverside
-
Saginaw, Michigan, United States, 48602
- Saginaw
-
-
Mississippi
-
Eupora, Mississippi, United States, 39744
- Eupora
-
Meridian, Mississippi, United States, 39301
- Meridian
-
Oxford, Mississippi, United States, 38655
- Yokna River
-
-
Missouri
-
Independence, Missouri, United States, 64057
- Independence Centerpoint
-
-
Nevada
-
Las Vegas, Nevada, United States, 89109
- Desert Inn
-
Las Vegas, Nevada, United States, 89120
- South Pecos
-
-
North Carolina
-
Durham, North Carolina, United States, 27703
- Briggs Ave
-
Durham, North Carolina, United States, 27704
- Freedom Lake
-
-
Ohio
-
Boardman, Ohio, United States, 44512
- Boardman
-
Cortland, Ohio, United States, 44410
- Cortland
-
Elyria, Ohio, United States, 44035
- Elyria
-
North Randall, Ohio, United States, 44128
- North Randall
-
Westlake, Ohio, United States, 44145
- Westlake
-
Willoughby, Ohio, United States, 44094
- Willoughby
-
-
Oregon
-
Beaverton, Oregon, United States, 97006
- Twin Oaks
-
Clackamas, Oregon, United States, 97015
- Clackamas
-
-
Tennessee
-
Brentwood, Tennessee, United States, 37027
- Fresenius Medical Services
-
Smyrna, Tennessee, United States, 37167
- Smyrna
-
West Nashville, Tennessee, United States, 37209
- West Nashville
-
-
Texas
-
Fort Worth, Texas, United States, 76119
- North Fort Worth
-
Fort Worth, Texas, United States, 76119
- Tarrant County
-
Waco, Texas, United States, 76708
- Waco
-
Waco, Texas, United States, 76712
- Waco West
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age ≥ 18
- resumption of routine outpatient chronic hemodialysis within three days of discharge from hospital admission
- enrolled in a facility-based anemia management program
Exclusion Criteria:
- enrolled in hospice
- previous hospitalization within the past 30 days (ie. patients discharged from a repeat hospitalization)
- anticipated discharge from the outpatient dialysis facility within 30 days (ie anticipated transfer to another facility or hospice)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Early anemia management
Upon return to the dialysis unit following hospitalization, patients will be immediately identified and have immediate implementation of the unit anemia protocol rather than waiting for the next regularly scheduled unit labs and regular follow-up.
Thus, labs will be obtained within the first 3-7 days following hospitalization and appropriate titration of Epo and iron medications within the 7 days after discharge from hospital and under the direction of the pre-specified algorithm used in the patient's facility; all drug dosing will comply with package insert instructions
|
Patients returning to the unit are immediately assessed and treated for anemia
|
Other: case control
Each case will be "data-matched" to an intra-facility (primary control), and then an inter-facility (validation control) control patient.
Matching criteria will be by age, gender, diabetic status, attending nephrologist, length of hospitalization stay, and hospital discharge date (to minimize the difference in the date between the case and control).
These patients did not have early intervention but followed the usual practice of waiting for the next regularly scheduled dialysis unit labs with anemia management to follow using the regular unit algorithm.
|
Normal unit policy for labs and anemia treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
composite of death or repeat hospitalization within the 30 days after discharge from a previous hospitalization
Time Frame: one year to accumulate 1500 hospitalizations
|
one year to accumulate 1500 hospitalizations
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
hemoglobin, transferrin saturation, albumin, white blood cell count, and C-reactive protein* levels measured in the period following hospitalization and change relative to values measured prior to hospitalization (where available).
Time Frame: one year to accumulate 1500 hospitalizations
|
one year to accumulate 1500 hospitalizations
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Raymond Hakim, M.D., Ph.D., Fresenius Medical Services
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2009
Primary Completion (Anticipated)
November 1, 2010
Study Completion (Anticipated)
December 1, 2010
Study Registration Dates
First Submitted
November 18, 2009
First Submitted That Met QC Criteria
November 19, 2009
First Posted (Estimate)
November 20, 2009
Study Record Updates
Last Update Posted (Estimate)
April 2, 2010
Last Update Submitted That Met QC Criteria
April 1, 2010
Last Verified
April 1, 2010
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20090068
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mortality
-
Duke UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsTerminated
-
University Hospital, Clermont-FerrandAustralian Catholic University; WittyFitUnknown
-
Duke-NUS Graduate Medical SchoolActive, not recruiting
-
Chimei Medical CenterCompleted
-
Queens College, The City University of New YorkNational Cancer Institute (NCI)UnknownMortality
-
FHI 360Ministère de la Santé et de l´Hygiène Publique (Côte d'Ivoire)Recruiting
-
University of California, San FranciscoBill and Melinda Gates Foundation; Centre de Recherche en Sante de Nouna, Burkina...CompletedChildhood MortalityBurkina Faso
-
Public Health Foundation of IndiaUBS Optimus Foundation; The Children's Investment Fund FoundationCompleted
-
Hospital Vila Franca de XiraUnknownHospital MortalityPortugal
Clinical Trials on Early anemia diagnosis and treatment
-
Fundacion para la Formacion e Investigacion Sanitarias...Unknown
-
UMC UtrechtEnrolling by invitationCoronary Artery Disease | Heart Failure | Atrial Fibrillation | Valvular Heart DiseaseNetherlands
-
Eastern Mediterranean UniversityActive, not recruitingCancer | Breast Cancer | Nursing Caries | Awakening Early | Breast Self-ExaminationCyprus
-
Assiut UniversityUnknownPediatric Dilated Cardiomyopathy
-
Charite University, Berlin, GermanyRecruiting
-
Elizabeth Glaser Pediatric AIDS FoundationUNITAIDCompletedHIV/AIDS | Infant Morbidity | Pediatric HIV Infection | Transmission, Perinatal InfectionKenya, Zimbabwe
-
Imperial College Healthcare NHS TrustNot yet recruitingCervical Myelopathy
-
Brigham and Women's HospitalBreast Cancer Research Foundation; Partners in Health; Rwanda Biomedical CentreCompletedBreast Cancer | Benign Breast DiseaseRwanda
-
University of AarhusDanish College of General Practitioners; Danish Committee for Health EducationCompleted
-
University of BolognaCompleted